These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4824534)

  • 1. Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.
    Spurrell RA; Krikler DM; Sowton E
    Br Heart J; 1974 Mar; 36(3):256-64. PubMed ID: 4824534
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of verapamil on supraventricular hyperkinetic arrhythmias: electrophysiological evaluations after recording of the His electrogram].
    Pavia L; Buttafarro A; Siracusano L; Freni F; Gugliandolo A; Bitto U; Casella G
    Boll Soc Ital Cardiol; 1978; 23(2):333-8. PubMed ID: 754789
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrophysiological actions of somatostatin on the atrioventricular junction in sinus rhythm and reentry tachycardia.
    Webb SC; Krikler DM; Hendry WG; Adrian TE; Bloom SR
    Br Heart J; 1986 Sep; 56(3):236-41. PubMed ID: 2875723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking effect of verapamil on conduction over a catecholamine-sensitive bypass tract in exercise-induced Wolff-Parkinson-White syndrome.
    Horio Y; Matsuyama K; Morikami Y; Rokutanda M; Hirata A; Okumura K; Takaoka K; Uchida H; Kugiyama K; Araki S
    J Am Coll Cardiol; 1984 Jul; 4(1):186-91. PubMed ID: 6736448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of verapamil.
    Vohra JK
    Drugs; 1977 Mar; 13(3):219-24. PubMed ID: 321206
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of Wolff-Parkinson-White syndrome: conduction through the Kent bundle seems to depend on the serum potassium level.
    Nakahara Y; Nakahara Y; Matsuyama E
    Clin Cardiol; 1985 Sep; 8(9):494-8. PubMed ID: 4042452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
    Spurrell RA; Thorburn CW; Camm J; Sowton E; Deuchar DC
    Br Heart J; 1975 Aug; 37(8):861-7. PubMed ID: 53057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil in cardiac arrhythmias: an overview.
    Vohra J
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():129-34. PubMed ID: 6749351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of new beta-blocking agent (DL-tiprenolol) on conduction within normal and anomalous atrioventricular pathways in Wolff-Parkinson-White syndrome.
    Roelandt J; Schamroth L; Hugenholtz PG
    Br Heart J; 1972 Dec; 34(12):1272-82. PubMed ID: 4405234
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrophysiological effect of verapamil (studies in patients with normal A-V conduction and with WPW syndrome)].
    García Civera R; Sanjuan Máñez R; López Camps V; Rodríguez Serra M; Blanquer Oliva R; Llacer Escorihuela A; Llavador Sanchis J
    Rev Esp Cardiol; 1976; 29(6):525-36. PubMed ID: 796911
    [No Abstract]   [Full Text] [Related]  

  • 11. A fresh look at cardiac arrhythmias. Therapy.
    Krikler DM
    Lancet; 1974 May; 1(7865):1034-7. PubMed ID: 4133713
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of verapamil on electrophysiologic characteristics of the accessory pathway in patients with Wolff-Parkinson-White syndrome].
    Molenda W; Telichowski C; Góral J; Banasiak W; Metner E; Petruk J
    Pol Tyg Lek; 1988 Sep; 43(36):1157-60. PubMed ID: 3251208
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electrophysiological effects of chloroacetyl ajmaline in Wolff-Parkinson-White syndrome].
    Touboul P; Gressard A; Atallah G; Chatelain MT; Delahaye JP
    Arch Mal Coeur Vaiss; 1978 Jul; 71(7):808-15. PubMed ID: 102281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of verapamil on sinusal function and on atrioventricular conduction along normal and abnormal pathways, in patients with pre-existing troubles of excitation conduction (author's transl)].
    Disertori M; Molinis G; Lanzetta T; Antonini L; Furlanello F
    G Ital Cardiol; 1976; 6(2):300-11. PubMed ID: 64371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.
    Gulamhusein S; Ko P; Carruthers SG; Klein GJ
    Circulation; 1982 Feb; 65(2):348-54. PubMed ID: 7053894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arrhythmia in a patient with pre-exitation WPW-syndrome].
    Olesch K; Belz GG
    Z Kreislaufforsch; 1970 Jul; 59(7):585-99. PubMed ID: 4107758
    [No Abstract]   [Full Text] [Related]  

  • 17. Newer antiarrhythmic drugs.
    Coumel P; Krikler D; Rosen MR; Wellens HJ; Zipes DP
    Pacing Clin Electrophysiol; 1978 Oct; 1(4):521-8. PubMed ID: 95646
    [No Abstract]   [Full Text] [Related]  

  • 18. Aprindine for treatment of supraventricular tachycardias. With particular application to Wolff-Parkinson-White syndrome.
    Zipes DP; Gaum WE; Foster PR; Rosen KM; Wu D; Amat-Y-Leon F; Noble RJ
    Am J Cardiol; 1977 Oct; 40(4):586-96. PubMed ID: 910722
    [No Abstract]   [Full Text] [Related]  

  • 19. Anomalous atrioventricular excitation (Wolff-Parkinson-White syndrome) persisting with ectopic impulse formation.
    Bermudez GA; Childers RW
    Chest; 1970 Oct; 58(4):405-6. PubMed ID: 5472843
    [No Abstract]   [Full Text] [Related]  

  • 20. Tachyarrhythmias in Wolff-Parkinson-White syndrome. Antiarrhythmic drug therapy.
    Chung EK
    JAMA; 1977 Jan; 237(4):376-9. PubMed ID: 576173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.